A Case-Based Discussion on Managing Adult Patients With C3G or IC-MPGN in the Era of Complement Inhibition
Kenar D. Jhaveri, MD
Shikha Wadhwani MD, MS
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
James Burton, DM, FRCP
Nihar R. Desai, MD, MPH
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
Ellie Kelepouris, MD, FACP, FAHA
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
Pauline A. Swift, PhD
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
Applying Best Practices in the Diagnosis of PSVT
Jennifer Carlquist, PA-C
Brian P. Rose, PA-C, MPH
How to Build a Standardized Episode Algorithm
Sean Pokorney, MD, MBA
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Jonathan Barratt, MD, PhD
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
An De Vriese, MD, PhD
Navigating KDIGO Guidance in IgAN
Jörg Latus, MD
Unmasking IgAN: Achieving Earlier Diagnosis
Translating Evidence into IgAN Care
The Future of IgAN Care
Chee Kay Cheung, MBChB, MRCP, PhD
CKD-aP Uncovered Prevalence & Pathophysiology
Steven Fishbane, MD
Nancy Helou, PhD
Itching for Answers: Holistic CKD-aP Care
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN